ITMI20030762A1 - HYDROCHLORIDE BUPROPION CRYSTALLIZATION PROCESS. - Google Patents

HYDROCHLORIDE BUPROPION CRYSTALLIZATION PROCESS.

Info

Publication number
ITMI20030762A1
ITMI20030762A1 ITMI20030762A ITMI20030762A1 IT MI20030762 A1 ITMI20030762 A1 IT MI20030762A1 IT MI20030762 A ITMI20030762 A IT MI20030762A IT MI20030762 A1 ITMI20030762 A1 IT MI20030762A1
Authority
IT
Italy
Prior art keywords
crystallization process
bupropion
hydrochloride
hydrochloride bupropion
crystallization
Prior art date
Application number
Other languages
Italian (it)
Inventor
Luca Florindo De
Massimo Ferrari
Fiorella Lombardi
Original Assignee
Erregierre Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erregierre Spa filed Critical Erregierre Spa
Priority to ITMI20030762 priority Critical patent/ITMI20030762A1/en
Priority to CA002549350A priority patent/CA2549350A1/en
Priority to PCT/EP2004/050495 priority patent/WO2004089873A1/en
Publication of ITMI20030762A1 publication Critical patent/ITMI20030762A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
ITMI20030762 2003-04-11 2003-04-11 HYDROCHLORIDE BUPROPION CRYSTALLIZATION PROCESS. ITMI20030762A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI20030762 ITMI20030762A1 (en) 2003-04-11 2003-04-11 HYDROCHLORIDE BUPROPION CRYSTALLIZATION PROCESS.
CA002549350A CA2549350A1 (en) 2003-04-11 2004-04-09 Process for crystallising bupropion hydrochloride
PCT/EP2004/050495 WO2004089873A1 (en) 2003-04-11 2004-04-09 Process for crystallising bupropion hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI20030762 ITMI20030762A1 (en) 2003-04-11 2003-04-11 HYDROCHLORIDE BUPROPION CRYSTALLIZATION PROCESS.

Publications (1)

Publication Number Publication Date
ITMI20030762A1 true ITMI20030762A1 (en) 2004-10-12

Family

ID=33156348

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI20030762 ITMI20030762A1 (en) 2003-04-11 2003-04-11 HYDROCHLORIDE BUPROPION CRYSTALLIZATION PROCESS.

Country Status (3)

Country Link
CA (1) CA2549350A1 (en)
IT (1) ITMI20030762A1 (en)
WO (1) WO2004089873A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101534808A (en) 2005-06-27 2009-09-16 拜维尔实验室国际有限公司 Modified-release formulations of a bupropion salt
WO2008099418A2 (en) * 2007-02-12 2008-08-21 Alembic Limited An improved process for preparing bupropion hydrochloride
CN106431943B (en) * 2016-09-13 2021-03-26 迪嘉药业集团有限公司 Preparation method of bupropion hydrochloride crystal
WO2022119981A1 (en) 2020-12-01 2022-06-09 Antecip Bioventures Ii Llc Bupropion and dextromethrophan for reduction of suicide risk in depression patients
US20240000729A1 (en) * 2022-06-30 2024-01-04 Axsome Therapeutics, Inc. Microparticles containing bupropion
US11717518B1 (en) 2022-06-30 2023-08-08 Antecip Bioventures Ii Llc Bupropion dosage forms with reduced food and alcohol dosing effects
US11730706B1 (en) 2022-07-07 2023-08-22 Antecip Bioventures Ii Llc Treatment of depression in certain patient populations
US11844797B1 (en) 2023-04-20 2023-12-19 Antecip Bioventures Ii Llc Combination of dextromethorphan and bupropion for treating depression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759838A (en) * 1969-12-04 1971-06-03 Wellcome Found KETONES WITH BIOLOGICAL ACTIVITY
US6238697B1 (en) * 1998-12-21 2001-05-29 Pharmalogix, Inc. Methods and formulations for making bupropion hydrochloride tablets using direct compression
US6306436B1 (en) * 2000-04-28 2001-10-23 Teva Pharmaceuticals Usa, Inc. Stabilized, acid-free formulation for sustained release of bupropion hydrochloride

Also Published As

Publication number Publication date
CA2549350A1 (en) 2005-10-21
WO2004089873A1 (en) 2004-10-21

Similar Documents

Publication Publication Date Title
NO2015003I1 (en) bupropion
DE602004023295D1 (en) MANUFACTURING PROCESS FOR CAPS
ITMI20050817A1 (en) DEALOGENATION PROCESS
BR0211391B1 (en) process for preparing 4-aminodiphenylamines.
ITMI20030762A1 (en) HYDROCHLORIDE BUPROPION CRYSTALLIZATION PROCESS.
ITMI20050383A1 (en) PROCESS FOR PREPARING PEROXIDE PERFLUOROPOLIETERS
ITRM20030429A0 (en) HEATED BLOWING MOLD FOR THERMO-STABILIZATION PROCESS.
BR0215511B1 (en) process for preparing diglycerides.
ITMI20022185A1 (en) PROCESS FOR THE PREPARATION OF PHENOL BY HYDRODEXYGENATION OF BENZENDIOLS.
ITRM20030083A0 (en) GLASSES FRAME.
ITMI20030150A1 (en) PROCESS TO PREPARE FLUOROALOGENOETERI.
ITMI20032165A1 (en) GABAPENTINE PREPARATION PROCESS
ITMI20041920A1 (en) PROCESS FOR THE PREPARATION OF N, N-DIISOPROPYL-3-2-HYDROXY-5-METHYLPHENYL-3-PHENYL-PROPABAMMINE
ITFI20030275A1 (en) PROCESS FOR GALACTOSE PREPARATION
ITMI20030444A1 (en) PROCESS TO PREPARE (PER) FLUOROALOGENOETERI.
BRPI0408548B1 (en) process for preparing atypical articles.
BRPI0617924A2 (en) production process and compound
ATE355060T1 (en) 2-METHOXYMETHYL-3-(3,4-DICHLOROPHENYL)-8- AZABICYCLO (3.2.1)OCTANTARTRATE SALTS
ITMI20040873A1 (en) 3-3.4 METHYLENEIXY-FENYL-2-METHYLPROPANAL PREPARATION PROCESS
ITMI20061573A1 (en) PROCESS FOR THE PREPARATION OF 1,1-DICHLORO-2-ALCHILETHYLENE
ITMI20030823A1 (en) ALCOHOS AND ARYOXYPHENOL PREPARATION PROCESS.
ITMI20021732A1 (en) PROCESS FOR PREPARING PEARLS.
ITMI20032059A1 (en) PROCESS FOR THE PREPARATION OF DOXIFLURIDINE.
DE10358553B8 (en) Pliers, especially pliers
ITSA20040012A1 (en) STERILIZATION PROCESS OF A GLUCOCORTICOSTEROID.